Hyman Charles D Trims Stake in Express Scripts Holding (ESRX)

Hyman Charles D cut its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 2.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 73,221 shares of the company’s stock after selling 2,108 shares during the quarter. Hyman Charles D’s holdings in Express Scripts were worth $5,465,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. ING Groep NV boosted its stake in shares of Express Scripts by 143.3% during the fourth quarter. ING Groep NV now owns 135,678 shares of the company’s stock valued at $10,127,000 after purchasing an additional 79,909 shares in the last quarter. Milestone Group Inc. boosted its stake in shares of Express Scripts by 57.3% during the fourth quarter. Milestone Group Inc. now owns 4,969 shares of the company’s stock valued at $371,000 after purchasing an additional 1,810 shares in the last quarter. Sompo Japan Nipponkoa Asset Management CO. LTD. boosted its stake in shares of Express Scripts by 12.4% during the fourth quarter. Sompo Japan Nipponkoa Asset Management CO. LTD. now owns 194,557 shares of the company’s stock valued at $14,522,000 after purchasing an additional 21,440 shares in the last quarter. First National Bank of Omaha boosted its stake in shares of Express Scripts by 7.4% during the fourth quarter. First National Bank of Omaha now owns 11,060 shares of the company’s stock valued at $825,000 after purchasing an additional 765 shares in the last quarter. Finally, Crossmark Global Holdings Inc. boosted its stake in shares of Express Scripts by 11.3% during the fourth quarter. Crossmark Global Holdings Inc. now owns 65,157 shares of the company’s stock valued at $4,863,000 after purchasing an additional 6,594 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

ESRX has been the topic of a number of recent research reports. Robert W. Baird increased their price objective on shares of Express Scripts from $57.00 to $59.00 and gave the company a “neutral” rating in a research note on Wednesday, October 25th. Zacks Investment Research downgraded shares of Express Scripts from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Royal Bank of Canada set a $66.00 target price on shares of Express Scripts and gave the company a “hold” rating in a research note on Wednesday, October 25th. TheStreet upgraded shares of Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Finally, Jefferies Group set a $80.00 target price on shares of Express Scripts and gave the company a “buy” rating in a research note on Friday, December 15th. Six analysts have rated the stock with a sell rating, eight have given a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $78.23.

In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP Glen D. Stettin sold 3,449 shares of the firm’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the transaction, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,001 shares of company stock valued at $1,249,505. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding (NASDAQ:ESRX) opened at $74.95 on Thursday. The stock has a market cap of $43,010.00, a price-to-earnings ratio of 12.45, a price-to-earnings-growth ratio of 0.84 and a beta of 0.93. Express Scripts Holding has a fifty-two week low of $55.80 and a fifty-two week high of $83.49. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86.

Express Scripts declared that its board has initiated a share buyback program on Monday, December 18th that authorizes the company to repurchase 45,000,000 shares. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

ILLEGAL ACTIVITY NOTICE: This piece was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.com-unik.info/2018/02/08/hyman-charles-d-trims-stake-in-express-scripts-holding-esrx.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit